Multicenter prospective study on prediction of primary resistance to anti PD-1/PD-L1 antibodies by hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI
Not Applicable
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000045557
- Lead Sponsor
- Kindai University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 165
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with malignant tumor of other organ that is difficult disease control 2) Patients with esophagogastric varices at high risk of rupture 3) Patients who are pregnant or who wish to have a baby during treatment 4) Refusal to give informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method